Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Richardet

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|January 1, 1995
[Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma]E Richardet, L Carranza, A Uribe, et al.
JCO Global Oncology|March 24, 2022
Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority StudyRuben D Kowalyszyn, Luis E Fein, Martin E Richardet, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
Uracil/tegafur plus oral calcium folinate in advanced breast cancerE Richardet, C Pedraza, E Mickiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsA Zori Comba, C Blajman, E Richardet, et al.
ESMO Open|May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LAD P Carbone, T-E Ciuleanu, M Cobo, et al.
ESMO Open|October 4, 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year updateM Reck, T-E Ciuleanu, M Cobo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|January 1, 1995
[Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma]E Richardet, L Carranza, A Uribe, et al.
JCO Global Oncology|March 24, 2022
Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority StudyRuben D Kowalyszyn, Luis E Fein, Martin E Richardet, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
Uracil/tegafur plus oral calcium folinate in advanced breast cancerE Richardet, C Pedraza, E Mickiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsA Zori Comba, C Blajman, E Richardet, et al.
ESMO Open|May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LAD P Carbone, T-E Ciuleanu, M Cobo, et al.
ESMO Open|October 4, 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year updateM Reck, T-E Ciuleanu, M Cobo, et al.
Pageof 1